Docosahexaenoic Acid Targets TRPC3/6 Channels to Suppress Noradrenaline-Induced Contraction in Rat Vas Deferens Smooth Muscle
Biological and Pharmaceutical Bulletin · 2025
DOI: 10.1248/bpb.b25-00428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Keisuke Obara und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan. Hauptthemen laut MEDLINE: TRPC Cation Channels, Muscle Contraction, Vas Deferens, Muscle, Smooth. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
We investigated the effects of docosahexaenoic acid (DHA) on noradrenaline (NA)-induced contractile responses in rat vas deferens smooth muscle (VDSM). DHA (3 × 10-6-3 × 10-5 M) significantly inhibited phasic contractions induced by NA (3 × 10-5 M) in a concentration-dependent manner. In contrast, under Ca2+-free conditions, DHA (3 × 10-5 M) slightly enhanced NA-induced contractile responses. DHA did not inhibit NA-induced contractile responses in the prostate, which are mediated by α1A-adrenoceptor stimulation, similar to those in VDSM. Although verapamil (10-5 M), an L-type Ca2+ channel inhibitor, partially suppressed NA-induced contractile responses in VDSM, a substantial phasic component persisted. The residual phasic component was unaffected by LOE-908 (a receptor-operated Ca2+ channel inhibitor, 3 × 10-5 M), but was markedly inhibited by SKF-96365 (an inhibitor of both receptor-operated and store-operated Ca2+ channels, 3 × 10-5 M). Among inhibitors targeting store-operated Ca2+ channel candidates with high mRNA expression in VDSM, GSK417651A (10-5 M) and Pyr10 (3 × 10-5 M)-both putative inhibitors of transient receptor potential canonical 3/6 (TRPC3/6) channels-effectively inhibited the contractile response, whereas inhibitors targeting Orai1, transient receptor potential vanilloid 4 (TRPV4), or TRPC1/4/5 did not exert inhibitory effects. Similarly, under combined treatment with verapamil and LOE-908, contractile responses induced by cyclopiazonic acid (3 × 10-5 M, a sarco/endoplasmic reticulum Ca2+-ATPase inhibitor) were reduced by DHA, SKF-96365, and putative TRPC3/6 inhibitors, but not by inhibitors of Orai1, TRPV4, or TRPC1/4/5. These findings indicate that DHA suppresses NA-induced contractile responses in VDSM, primarily through inhibition of TRPC3/6 channels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan.
- Department of Organic Chemistry, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan.
Zitieren
APA
Obara, K., Enomoto, M., Furuta, M., Okura, H., Kato, A., Mouri, T., Gohara, M., Ura, T., Nasu, H., Yoshioka, K., Kusakabe, T., Takahashi, K., Kato, K., & Tanaka, Y. (2025). Docosahexaenoic Acid Targets TRPC3/6 Channels to Suppress Noradrenaline-Induced Contraction in Rat Vas Deferens Smooth Muscle. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00428
Vancouver
Obara K, Enomoto M, Furuta M, Okura H, Kato A, Mouri T, et al. Docosahexaenoic Acid Targets TRPC3/6 Channels to Suppress Noradrenaline-Induced Contraction in Rat Vas Deferens Smooth Muscle. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b25-00428
BibTeX
@article{Obara2025,
author = {Obara, Keisuke and Enomoto, Miwa and Furuta, Mio and Okura, Haruka and Kato, Ayu and Mouri, Taisei and Gohara, Minori and Ura, Tomohiro and Nasu, Hiyori and Yoshioka, Kento and Kusakabe, Taichi and Takahashi, Keisuke and Kato, Keisuke and Tanaka, Yoshio},
title = {Docosahexaenoic Acid Targets TRPC3/6 Channels to Suppress Noradrenaline-Induced Contraction in Rat Vas Deferens Smooth Muscle},
journal = {Biological and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/bpb.b25-00428}
}
EUVIMED